Medical Economics January 21, 2025
Austin Littrell

Key Takeaways

  • The Medicare $2 Drug List Model aims to improve medication adherence and prescriber satisfaction by offering low-cost generic drugs.
  • ACP supports the model but stresses the importance of monitoring its implementation to prevent negative impacts on prescribers and patients.
  • The model includes 101 medications across 15 clinical categories and allows for flexibility in updating the drug list.
  • ACP advocates for timely communication of changes to the drug list to ensure uninterrupted treatment for patients.

The potential CMS model would set a $2 copayment for common generic drugs in an effort to improve medication adherence.

In response to a request for information, the American College of Physicians (ACP) expressed their support for the aim of the Medicare...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Physician, Provider
Musk's team accesses Medicare, Medicaid records
Musk’s DOGE Reportedly Digging Into Medicare Payment System
DOGE turns focus to CMS spending, contracts, news report says
Are Medicare Fee Schedules Appropriate For Commercial Populations?
Medicare's 2025 physician pay cut, explained

Share This Article